This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
n9	http://dx.doi.org/10.1002/
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q43445759

rdf:type

wikibase:Item

schema:description

επιστημονικό άρθρο 2013年學術文章 scientific article published on 30 August 2013 научна статия bilimsel makale articolo scientifico 2013年学术文章 мақолаи илмӣ artículo científico publicado en 2013 2013 nî lūn-bûn teaduslik artikkel naučni članak artigo científico 2013年學術文章 vitenskapelig artikkel научни чланак bài báo khoa học artykuł naukowy artikel ilmiah 2013年の論文 2013年学术文章 2013年学术文章 სამეცნიერო სტატია 2013年學術文章 scientific article published on 30 August 2013 artikull shkencor wetenschappelijk artikel научная статья tieteellinen artikkeli מאמר מדעי wissenschaftlicher Artikel научни чланак artigo científico 2013年學術文章 artículu científicu espublizáu en 2013 2013년 논문 videnskabelig artikel scientific article published on 30 August 2013 наукова стаття, опублікована в серпні 2013 vědecký článek articol științific 2013年学术文章 article scientifique ৩০ আগস্ট ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk 2013年學術文章 artikulong pang-agham 2013年学术文章 vetenskaplig artikel article científic article scientific مقالة علمية نشرت في 30 أغسطس 2013 2013年学术文章 vedecký článok scienca artikolo artigo científico บทความทางวิทยาศาสตร์ vitskapeleg artikkel

p:P577

wds:Q43445759-F2DE0A22-B457-4492-805E-6E0D8F734AA6

wdt:P577

2013-08-30T00:00:00Z

p:P2860

wds:Q43445759-6D5D3BD1-6AAF-400B-850A-5B673E4C474D wds:Q43445759-6D6B1330-4F7A-4B8B-9FAE-A2EFA32D5CFB wds:Q43445759-3A7D6B0D-BFB2-4CEB-A763-9C5E184B3C27 wds:Q43445759-3D505528-DE37-43CB-B095-1C41A65D88A5 wds:Q43445759-409E8932-23A1-4511-A8F2-49D1316DBFCF wds:Q43445759-D3510122-2507-40C0-AA3B-04D7F0DA0837 wds:Q43445759-89CAC19B-C37A-4F5A-9BF2-B510BFF603CC wds:Q43445759-8A6E90B5-A158-4EBF-A034-B2C467A2FB66 wds:Q43445759-8DF8DE40-6B77-4B0A-9CA4-C77C1C39508C wds:Q43445759-C5CAB494-7BDF-431C-8765-77B3D796B5DD wds:Q43445759-B3985450-E588-4F00-9955-895761B00D33 wds:Q43445759-B5983B34-0EB7-43D9-953B-E5FA2AC3FA34 wds:Q43445759-2360D9CD-75BA-4205-88DC-C4BE61A401DD

wdt:P2860

wd:Q51602211 wd:Q53564660 wd:Q30318425 wd:Q52891298 wd:Q37780048 wd:Q50871038 wd:Q37795680 wd:Q36991508 wd:Q35710639 wd:Q51142338 wd:Q41962966 wd:Q51170332 wd:Q57914294

p:P2093

wds:Q43445759-23FB9E3B-757D-4D80-8043-43BD71358A9A wds:Q43445759-621E90CA-52C5-4860-AB8E-784CD618CD7C wds:Q43445759-8942EB3D-822B-4918-87FE-DFFD1A5AE417 wds:Q43445759-7E3614BC-A077-4250-A802-13BDF062B4FC wds:Q43445759-C359A129-5743-4763-B65A-A9B617139E0C wds:Q43445759-E26E2BD9-C259-442E-8468-F0068C326525 wds:Q43445759-E954F604-B968-4069-BCA8-ECBE6C11FF27 wds:Q43445759-FFD3D965-2A41-4631-8F1D-B9FDAF1F97E7

wdt:P2093

Tsuyoshi Sanuki Mamoru Takenaka Tsuyoshi Fujita Takanobu Hayakumo Hiromu Kutsumi Takeshi Azuma Atsuhiro Masuda Hideyuki Shiomi

rdfs:label

What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.

skos:prefLabel

What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.

schema:name

What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.

p:P50

wds:Q43445759-051A928A-A13B-45AD-9B44-ACEAF8CBDC33 wds:Q43445759-7F266669-F986-427C-B45C-D6A64CDFA5CF

wdt:P50

wd:Q11522114 wd:Q79446701

p:P1476

wds:Q43445759-7F487E35-B1D1-4F7D-9A09-4F22C217B2B9

wdt:P1476

What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis

p:P304

wds:Q43445759-53F7E1E2-73C8-411E-915F-BD315FA4F8C6

wdt:P304

275-280

p:P31

wds:Q43445759-CB94FA8E-F204-4EFA-A631-BB4593937B99

wdt:P31

wd:Q13442814

p:P921

wds:Q43445759-960F9EA9-046B-4EA2-9E89-99AF6A9E224C

wdt:P921

wd:Q64624681

p:P698

wds:Q43445759-9F6439C4-52B2-449C-858A-9A492E9160DC

wdtn:P698

n11:24039185

wdt:P698

24039185

p:P1433

wds:Q43445759-0325C4CA-6620-41DF-B9EC-D5043990B23B

wdt:P1433

wd:Q25378879

p:P433

wds:Q43445759-BD4B3214-971B-476D-989B-24BFC66D8A63

p:P478

wds:Q43445759-A98573CC-F25A-4BB2-8B8F-A9E6D9F071F9

wdt:P433

4

wdt:P478

21

p:P356

wds:Q43445759-B774A99B-C2B1-4876-BCF2-F978C8170C11

wdtn:P356

n9:JHBP.24

wdt:P356

10.1002/JHBP.24

p:P5875

wds:Q43445759-19A5CA09-5F03-4070-A3F6-D96D6C36B3E4

wdt:P5875

256613596